CNTB
CNTB
NASDAQ · Biotechnology

Connect Biopharma Holdings L

$2.43
+0.13 (+5.65%)
As of Feb 8, 2:09 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +746.1% upside
Low Target $15.18
Average Target $20.56
High Target $23.56
Current Price $2.43
Current
$2.43
Target
$20.56
$15.18 $20.56 avg $23.56
Scenario Analysis
Bear Case
$15.18
524.7%
Low target
Base Case
$20.56
+746.1%
Avg target
Bull Case
$23.56
+869.5%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$25.73
-90.6% from high
52-Week Low
$13.35
+-81.8% from low
Target vs 52W High
$20.56
-20.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%